Product Program year 2020 Source: CMS Open Payments

Omeclamox-Pak

Drug Gastroenterology

NDC 66220-422-01

Open in the dashboard

General payments

$2,273

142 payments

Research payments

$0

0 payments

Through program year 2020, $2,273 in general payments and $0 in research payments were reported against Omeclamox-Pak (Gastroenterology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2020 General $2,273 142

Breakdown

Who paid General payments · program year 2020
  1. Cumberland Pharmaceuticals, Inc. $2,273 142 payments
Top recipients General payments · program year 2020
  1. Luis Gonzalez Internal Medicine · Silver Spring, MD $81 4% · 4 payments
  2. Darlene Negbenebor Stamford, CT $75 3% · 5 payments
  3. Sonya Ventour Gastroenterology · Baldwin, NY $68 3% · 4 payments
  4. Mohammed Azim Family Medicine · Manassas, VA $60 3% · 3 payments
  5. Joyce Koh Gastroenterology · Bend, OR $58 3% · 3 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Gastroenterology Internal Medicine $1,348 62% · 64 practitioners
  2. Internal Medicine $353 16% · 13 practitioners
  3. Family Medicine $188 9% · 10 practitioners
  4. Anesthesiology $126 6% · 6 practitioners
  5. Pediatric Gastroenterology Pediatrics $27 1% · 2 practitioners

The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. New York $672 30% · 32 recipients
  2. Texas $420 18% · 30 recipients
  3. Maryland $344 15% · 10 recipients
  4. New Jersey $342 15% · 13 recipients
  5. Florida $197 9% · 11 recipients

The top 5 of 10 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

142 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record